AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 1-25/70
TAILORED THERAPY TO EQUAL TOXICITY - IS IT POSSIBLE
Authors: BERGH J
Citation: J. Bergh, TAILORED THERAPY TO EQUAL TOXICITY - IS IT POSSIBLE, European journal of cancer, 34, 1998, pp. 32-32
SECTOR RESECTION WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY FOR STAGE-I BREAST-CANCER - LONG-TERM RESULTS AND DEFINITION OF A SUBGROUP NOT REQUIRING RADIOTHERAPY
Authors: LILJEGREN G HOLMBERG L ADAMI HO BERGH J
Citation: G. Liljegren et al., SECTOR RESECTION WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY FOR STAGE-I BREAST-CANCER - LONG-TERM RESULTS AND DEFINITION OF A SUBGROUP NOT REQUIRING RADIOTHERAPY, European journal of cancer, 34, 1998, pp. 61-61
MULTIMODALITY THERAPY OF 128 PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER IN THE ERA OF MAMMOGRAPHY SCREENING USING STANDARD FEC-PROGNOSTICAND THERAPEUTIC IMPLICATIONS
Authors: KARLSSON Y MALMSTROM P HATSCHEK T FORNANDER T SODERBERG M BENGTSSON NO JANSSON T SJOBERG S BERGH J
Citation: Y. Karlsson et al., MULTIMODALITY THERAPY OF 128 PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER IN THE ERA OF MAMMOGRAPHY SCREENING USING STANDARD FEC-PROGNOSTICAND THERAPEUTIC IMPLICATIONS, European journal of cancer, 34, 1998, pp. 76-76
HOMOZYGOUS DELETIONS AT 3P12 IN BREAST AND LUNG-CANCER
Authors: SUNDARESAN V CHUNG G HEPPELLPARTON A XIONG J GRUNDY C ROBERTS I JAMES L CAHN A BENCH A DOUGLAS J MINNA J SEKIDO Y LERMAN M LATIF F BERGH J LI H LOWE N OGILVIE D RABBITTS P
Citation: V. Sundaresan et al., HOMOZYGOUS DELETIONS AT 3P12 IN BREAST AND LUNG-CANCER, Oncogene, 17(13), 1998, pp. 1723-1729
DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS
Authors: BERGH J WIKLUND T ERIKSTEIN B FORNANDER T BENGTSSON NO MALMSTROM P KELLOKUMPULEHTINEN P ANKER G BENNMARKER H WILKING N
Citation: J. Bergh et al., DOSAGE OF ADJUVANT G-CSF (FILGRASTIM) SUPPORTED FEC POLYCHEMOTHERAPY BASED ON EQUIVALENT HEMATOLOGICAL TOXICITY IN HIGH-RISK BREAST-CANCER PATIENTS, Annals of oncology, 9(4), 1998, pp. 403-411
PROGNOSTIC AND PREDICTIVE VALUE OF C-ERBB-2 OVEREXPRESSION IN PRIMARYBREAST-CANCER, ALONE AND IN COMBINATION WITH OTHER PROGNOSTIC MARKERS
Authors: SJOGREN S INGANAS M LINDGREN A HOLMBERG L BERGH J
Citation: S. Sjogren et al., PROGNOSTIC AND PREDICTIVE VALUE OF C-ERBB-2 OVEREXPRESSION IN PRIMARYBREAST-CANCER, ALONE AND IN COMBINATION WITH OTHER PROGNOSTIC MARKERS, Journal of clinical oncology, 16(2), 1998, pp. 462-469
CLIMATIC FACTORS CONTROLLING THE PRODUCTIVITY OF NORWAY SPRUCE - A MODEL-BASED ANALYSIS
Authors: BERGH J MCMURTRIE RE LINDER S
Citation: J. Bergh et al., CLIMATIC FACTORS CONTROLLING THE PRODUCTIVITY OF NORWAY SPRUCE - A MODEL-BASED ANALYSIS, Forest ecology and management, 110(1-3), 1998, pp. 127-139
SKELETAL METASTASES FROM BREAST-CANCER - UPTAKE OF F-18 FLUORIDE MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY IN CORRELATION WITH CT
Authors: PETRENMALLMIN M ANDREASSON I LJUNGGREN O AHLSTROM H BERGH J ANTONI G LANGSTROM B BERGSTROM M
Citation: M. Petrenmallmin et al., SKELETAL METASTASES FROM BREAST-CANCER - UPTAKE OF F-18 FLUORIDE MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY IN CORRELATION WITH CT, Skeletal radiology, 27(2), 1998, pp. 72-76
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE-IV BREAST-CANCER
Authors: LJUNGMAN P BJORKSTRAND B FORNANDER T HOGLUND M JULIUSSON G LINDMAN H MALMSTROM A ROTSTEIN S SODERBERG M WILKING N VILLMAN K BERGH J
Citation: P. Ljungman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE-IV BREAST-CANCER, Bone marrow transplantation, 22(5), 1998, pp. 445-448
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE IV BREAST-CANCER
Authors: LJUNGMAN P BJORKSTRAND B FORNANDER T HOGLUND M JULIUSSON G MALMSTROM A LINDMAN H ROTSTEIN S SODERBERG M WILKING N VILLMAN K BERGH J
Citation: P. Ljungman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE IV BREAST-CANCER, Bone marrow transplantation, 21, 1998, pp. 219-219
SPONTANEOUS AND RADIATION-INDUCED APOPTOSIS IN LUNG-CARCINOMA CELLS WITH DIFFERENT INTRINSIC RADIOSENSITIVITIES
Authors: SIRZEN F ZHIVOTOVSKY B NILSSON A BERGH J LEWENSOHN R
Citation: F. Sirzen et al., SPONTANEOUS AND RADIATION-INDUCED APOPTOSIS IN LUNG-CARCINOMA CELLS WITH DIFFERENT INTRINSIC RADIOSENSITIVITIES, Anticancer research, 18(2A), 1998, pp. 695-699
PRODUCTION OF A MOTILITY FACTOR BY A NEWLY ESTABLISHED LUNG ADENOCARCINOMA CELL-LINE
Authors: KLOMINEK J ROBERT KH BERGH J HJERPE A GAHRTON G SUNDQVIST KG
Citation: J. Klominek et al., PRODUCTION OF A MOTILITY FACTOR BY A NEWLY ESTABLISHED LUNG ADENOCARCINOMA CELL-LINE, Anticancer research, 18(2A), 1998, pp. 759-767
ENHANCED EXPRESSION OF NEUROPEPTIDES IN HUMAN BREAST-CANCER CELL-LINES FOLLOWING IRRADIATION
Authors: AALTO Y FORSGREN S KJORELL U BERGH J FRANZEN L HENRIKSSON R
Citation: Y. Aalto et al., ENHANCED EXPRESSION OF NEUROPEPTIDES IN HUMAN BREAST-CANCER CELL-LINES FOLLOWING IRRADIATION, Peptides, 19(2), 1998, pp. 231-239
RADIOTHERAPY OF BREAST-CANCER AFTER BREAST-CONSERVING SURGERY - AN IMPROVED TECHNIQUE USING MIXED ELECTRON-PHOTON BEAMS WITH A MULTILEAF COLLIMATOR
Authors: JANSSON T LINDMAN H NYGARD K DAHLGREN CV MONTELIUS A OBERGKREUGER C ASPLUND S BERGH J
Citation: T. Jansson et al., RADIOTHERAPY OF BREAST-CANCER AFTER BREAST-CONSERVING SURGERY - AN IMPROVED TECHNIQUE USING MIXED ELECTRON-PHOTON BEAMS WITH A MULTILEAF COLLIMATOR, Radiotherapy and oncology, 46(1), 1998, pp. 83-89
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
COMPARISON BETWEEN P53 PROTEIN MEASUREMENTS USING THE LUMINOMETRIC IMMUNOASSAY AND IMMUNOHISTOCHEMISTRY WITH DETECTION OF P53 GENE-MUTATIONS USING CDNA SEQUENCING IN HUMAN BREAST-TUMORS
Authors: NORBERG T LENNERSTRAND J INGANAS M BERGH J
Citation: T. Norberg et al., COMPARISON BETWEEN P53 PROTEIN MEASUREMENTS USING THE LUMINOMETRIC IMMUNOASSAY AND IMMUNOHISTOCHEMISTRY WITH DETECTION OF P53 GENE-MUTATIONS USING CDNA SEQUENCING IN HUMAN BREAST-TUMORS, International journal of cancer, 79(4), 1998, pp. 376-383
A GENERAL-MODEL FOR TIME-DISSOCIATED PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS EXEMPLIFIED BY PACLITAXEL MYELOSUPPRESSION
Authors: KARLSSON MO MOLNAR V BERGH J FREIJS A LARSSON R
Citation: Mo. Karlsson et al., A GENERAL-MODEL FOR TIME-DISSOCIATED PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS EXEMPLIFIED BY PACLITAXEL MYELOSUPPRESSION, Clinical pharmacology and therapeutics, 63(1), 1998, pp. 11-25
ASSESSMENT OF SEQUENCE-BASED P53 GENE ANALYSIS IN HUMAN BREAST-CANCER- MESSENGER-RNA IN COMPARISON WITH GENOMIC DNA TARGETS
Authors: WILLIAMS C NORBERG T AHMADIAN A PONTEN F BERGH J INGANAS M LUNDEBERG J UHLEN M
Citation: C. Williams et al., ASSESSMENT OF SEQUENCE-BASED P53 GENE ANALYSIS IN HUMAN BREAST-CANCER- MESSENGER-RNA IN COMPARISON WITH GENOMIC DNA TARGETS, Clinical chemistry, 44(3), 1998, pp. 455-462
TIME FOR INTEGRATION OF PREDICTIVE FACTORS FOR SELECTION OF BREAST-CANCER PATIENTS WHO NEED POSTOPERATIVE RADIATION-THERAPY
Authors: BERGH J
Citation: J. Bergh, TIME FOR INTEGRATION OF PREDICTIVE FACTORS FOR SELECTION OF BREAST-CANCER PATIENTS WHO NEED POSTOPERATIVE RADIATION-THERAPY, Journal of the National Cancer Institute, 89(9), 1997, pp. 605-607
ALKALINE SINGLE-CELL GEL-ELECTROPHORESIS AND HUMAN BIOMONITORING FOR GENOTOXICITY - A PILOT-STUDY ON BREAST-CANCER PATIENTS UNDERGOING CHEMOTHERAPY INCLUDING CYCLOPHOSPHAMIDE
Authors: VAGHEF H NYGREN P EDLING C BERGH J HELLMAN B
Citation: H. Vaghef et al., ALKALINE SINGLE-CELL GEL-ELECTROPHORESIS AND HUMAN BIOMONITORING FOR GENOTOXICITY - A PILOT-STUDY ON BREAST-CANCER PATIENTS UNDERGOING CHEMOTHERAPY INCLUDING CYCLOPHOSPHAMIDE, Mutation research. Genetic toxicology and environmental mutagenesis, 395(2-3), 1997, pp. 127-138
DUCTAL CARCINOMA IN-SITU OF THE BREAST, AN EVALUATION OF A NEW HISTOPATHOLOGICAL CLASSIFICATION-SYSTEM
Authors: WARNBERG F NORDGREN H HELMBERG L BERGH J
Citation: F. Warnberg et al., DUCTAL CARCINOMA IN-SITU OF THE BREAST, AN EVALUATION OF A NEW HISTOPATHOLOGICAL CLASSIFICATION-SYSTEM, European journal of cancer, 33, 1997, pp. 880-880
THE COST-EFFECTIVENESS OF ROUTINE POSTOPERATIVE RADIOTHERAPY AFTER SECTOR RESECTION AND AXILLARY DISSECTION FOR BREAST-CANCER STAGE-I - RESULTS FROM A RANDOMIZED TRIAL
Authors: LILJEGREN G KARLSSON G BERGH J HOLMBERG L
Citation: G. Liljegren et al., THE COST-EFFECTIVENESS OF ROUTINE POSTOPERATIVE RADIOTHERAPY AFTER SECTOR RESECTION AND AXILLARY DISSECTION FOR BREAST-CANCER STAGE-I - RESULTS FROM A RANDOMIZED TRIAL, Annals of oncology, 8(8), 1997, pp. 757-763
RISK-FACTORS FOR LOCAL RECURRENCE AFTER CONSERVATIVE TREATMENT IN STAGE-I BREAST-CANCER - DEFINITION OF A SUBGROUP NOT REQUIRING RADIOTHERAPY
Authors: LILJEGREN G LINDGREN A BERGH J NORDGREN H TABAR L HOLMBERG L
Citation: G. Liljegren et al., RISK-FACTORS FOR LOCAL RECURRENCE AFTER CONSERVATIVE TREATMENT IN STAGE-I BREAST-CANCER - DEFINITION OF A SUBGROUP NOT REQUIRING RADIOTHERAPY, Annals of oncology, 8(3), 1997, pp. 235-241
DOSE INTENSITY IN PATIENTS WITH METASTATIC BREAST-CANCER - TIME FOR NOVEL THOUGHTS
Authors: BERGH J
Citation: J. Bergh, DOSE INTENSITY IN PATIENTS WITH METASTATIC BREAST-CANCER - TIME FOR NOVEL THOUGHTS, Annals of oncology, 8(2), 1997, pp. 109-110
THE FUTURE OF THE SOUTH-AFRICAN-HISTORICAL-SOCIETY - PRESIDENTIAL-ADDRESS TO THE 16TH BIENNIAL CONFERENCE OF THE SOUTH-AFRICAN-HISTORICAL-SOCIETY, UNIVERSITY-OF-PRETORIA, JULY 6-9, 1997
Authors: BERGH J
Citation: J. Bergh, THE FUTURE OF THE SOUTH-AFRICAN-HISTORICAL-SOCIETY - PRESIDENTIAL-ADDRESS TO THE 16TH BIENNIAL CONFERENCE OF THE SOUTH-AFRICAN-HISTORICAL-SOCIETY, UNIVERSITY-OF-PRETORIA, JULY 6-9, 1997, South african historical journal, (37), 1997, pp. 156-166
Risultati: 1-25 | 26-50 | 51-70